Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest DCF Advisers, LLC Stock Portfolio

$203Million– No. of Holdings #69

DCF Advisers, LLC Performance:
2024 Q1: 7.38%YTD: 7.38%2023: 12.44%

Performance for 2024 Q1 is 7.38%, and YTD is 7.38%, and 2023 is 12.44%.

About DCF Advisers, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, DCF Advisers, LLC reported an equity portfolio of $203 Millions as of 31 Mar, 2024.

The top stock holdings of DCF Advisers, LLC are MU, GOOG, REGN. The fund has invested 9.3% of it's portfolio in MICRON TECHNOLOGY INC and 5.4% of portfolio in ALPHABET INC.

The fund managers got completely rid off IMMUNOGEN INC (IMGN), ALNYLAM PHARMACEUTICALS INC (ALNY) and ROBLOX CORP (RBLX) stocks. They significantly reduced their stock positions in BURFORD CAP LTD (BUR), AT&T INC (T) and ALTIMMUNE INC (ALT). DCF Advisers, LLC opened new stock positions in BAIDU INC (BIDU), TELADOC HEALTH INC (TDOC) and SAMSARA INC (IOT). The fund showed a lot of confidence in some stocks as they added substantially to WOLFSPEED INC (WOLF), VANECK ETF TRUST (AFK) and BOEING CO (BA).
DCF Advisers, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

DCF Advisers, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that DCF Advisers, LLC made a return of 7.38% in the last quarter. In trailing 12 months, it's portfolio return was 17.25%.

New Buys

Ticker$ Bought
baidu inc2,026,640
teladoc health inc776,140
coherus biosciences inc578,250
revance therapeutics inc426,000
samsara inc377,900
palo alto networks inc284,130

New stocks bought by DCF Advisers, LLC

Additions to existing portfolio by DCF Advisers, LLC

Reductions

Ticker% Reduced
burford cap ltd-24.4
at&t inc-17.72
altimmune inc-16.49
regeneron pharmaceuticals-13.11
general mtrs co-12.5
xencor inc-11.86
pfizer inc-10.47
oracle corp-7.39

DCF Advisers, LLC reduced stake in above stock

Sold off

Ticker$ Sold
immunogen inc-415,100
united sts nat gas fd lp-58,305
roblox corp-228,600
alnylam pharmaceuticals inc-248,833

DCF Advisers, LLC got rid off the above stocks

Sector Distribution

DCF Advisers, LLC has about 31% of it's holdings in Healthcare sector.

Sector%
Healthcare31
Technology24.7
Others23.6
Communication Services8
Financial Services3.7
Energy3
Consumer Cyclical3
Consumer Defensive1.5

Market Cap. Distribution

DCF Advisers, LLC has about 61% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP33.9
MEGA-CAP27.1
UNALLOCATED23.6
SMALL-CAP8.1
MID-CAP4.8
MICRO-CAP2.4

Stocks belong to which Index?

About 69% of the stocks held by DCF Advisers, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
S&P 50056.3
Others31
RUSSELL 200012.7
Top 5 Winners (%)%
ADES
arq inc
113.2 %
MU
micron technology inc
38.0 %
META
meta platforms inc
37.2 %
LCTX
lineage cell therapeutics in
35.6 %
LLY
lilly eli & co
33.5 %
Top 5 Winners ($)$
MU
micron technology inc
5.2 M
LLY
lilly eli & co
1.4 M
AMD
advanced micro devices inc
1.3 M
REGN
regeneron pharmaceuticals
1.0 M
ABBV
abbvie inc
0.9 M
Top 5 Losers (%)%
RVNC
revance therapeutics inc
-43.5 %
PRTA
prothena corp plc
-28.5 %
YETI
yeti hldgs inc
-22.4 %
TDOC
teladoc health inc
-22.3 %
KIRK
kirklands inc
-20.2 %
Top 5 Losers ($)$
PRTA
prothena corp plc
-1.1 M
RVNC
revance therapeutics inc
-1.0 M
AAPL
apple inc
-0.3 M
LNDC
lifecore biomedical inc
-0.3 M
INCY
incyte corp
-0.3 M

DCF Advisers, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of DCF Advisers, LLC

DCF Advisers, LLC has 69 stocks in it's portfolio. About 40.7% of the portfolio is in top 10 stocks. PRTA proved to be the most loss making stock for the portfolio. MU was the most profitable stock for DCF Advisers, LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions